Tokyo, Japan -Jun 30, 2025- Axcelead, Inc. announces that the following executive appointments were approved at the Annual General Meeting of Shareholders held on June 30, 2025, and the subsequent meeting of the Board of Directors convened on the same day.

１. Directors (Effective June 30, 2025)

Name	New　/ Reappointment	Position
Yoshinori Ikeura	Reappointment	Representative Director
Hiroki Maekawa	New	Representative Director
Yuki Hasegawa	New	Board Director
Tadashi Takiguchi	Reappointment	External Board Director
Nobuhiko Yamada	–	Director (Full-time Audit Board Member)
Takuji Ikuta	–	Outside Director (Audit Committee Member)
Emi Kunitomo	–	Outside Director (Audit Committee Member)

(Note1) Nobuhiro Todokoro, Tomoyuki Fujisawa, Satoshi Iino, Junichi Kajimoto, and Seiji Toyama retired from their positions upon the expiration of their terms at the conclusion of the Annual General Meeting of Shareholders held on June 30, 2025.
(Note 2) Yuki Hasegawa is a board director seconded from Whiz Partners Inc.

[Reason for the Change of Representative Directors]
To promptly address various management challenges arising from business expansion and to further accelerate growth.

２. Management Team (as of July 1, 2025)　

Name	Position and Responsibilities	(Former Position and Responsibilities)
Yoshinori Ikeura	Representative Director, President and CEO	(Borad Director, Co-CEO and CTO)
Hiroki Maekawa	Representative Director, CFO	(Corporate Officer, CFO Finance, General Affairs, Legal, Public Relations & Investor Relations, Group IT Management)
Masamichi Sato	Corporate Officer, Corporate Strategy Planning	–
Miho Fujisawa	Corporate Officer, Human Resources	–
Satoshi Takamatsu	Corporate Officer, mRNA CDMO Business	–
Kengo Okada	Corporate Officer, Drug Discovery Support Business	–

• CTO：Chief Technology Officer

About Axcelead

Axcelead is a healthcare platform company centered around two core subsidiaries: Axcelead Drug Discovery Partners, Inc., a pioneering drug discovery solution provider, and ARCALIS Inc., a cutting-edge CDMO company specializing in the integrated manufacturing of mRNA pharmaceuticals. With the vision of becoming the world’s most trusted and innovative healthcare platform company, Axcelead is committed to driving innovation and delivering a groundbreaking healthcare platform to a diverse range of clients. Our mission is to help realize a healthier future for people around the world.https://www.axcelead-hd.com/en-home/

Press release in English